<mods:mods version="3.3" xsi:schemaLocation="http://www.loc.gov/mods/v3 http://www.loc.gov/standards/mods/v3/mods-3-3.xsd" xmlns:mods="http://www.loc.gov/mods/v3" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"><mods:titleInfo><mods:title>SURXONDARYO VILOYATI MISOLIDA SURUNKALI VIRUSLI GEPATIT C KASALLIGI ZAMONAVIY KLINIK VA EPIDEMIOLOGIK XUSUSIYATLARI.</mods:title></mods:titleInfo><mods:name type="personal"><mods:namePart type="given">Amonov Sobirjon</mods:namePart><mods:namePart type="family">Baxtiyorovich</mods:namePart><mods:role><mods:roleTerm type="text">author</mods:roleTerm></mods:role></mods:name><mods:abstract>Butun Jahon Sog‘liqni Saqlash Tashkilotining (JSST) tomonidan qabul qilingan bir qator hujjatlarga ko‘ra B va C virusli gepatitlarini bartaraf etishga erishish bugungi kundagi dolzarb muammolardan biri bo‘lib qolmoqda. JSSTning virusli gepatit bo‘yicha sog‘liqni saqlash sektorining global strategiyasi «...2030-yilga qadar kasallanishni 6-10 million holatdan 1 milliondan kam holatgacha kamaytirish, o‘lim ko‘rsatkichini 1,4 milliondan 500,000 dan kamaytirishga qaratilgan....». JSST hisobotlariga ko‘ra, dunyoda taxminan 50 million kishida surunkali gepatit C virusi infeksiyasi mavjud bo‘lib, har yili 1,0 millionga yaqin yangi yuqish holatlari kuzatilmoqda (JSST 9 April 2024). Jahonda virusli B va C gepatitlarini bartaraf qilish dasturi doirasida turli diagnostika yondashuvlarni qiyosiy baholashni takomillashtirish maqsadida qator ilmiy tadqiqotlar amalga oshirilmoqda.</mods:abstract><mods:originInfo><mods:dateIssued encoding="iso8601">2025-11-20</mods:dateIssued></mods:originInfo><mods:originInfo><mods:publisher>"Research Science and Innovation house" LLC</mods:publisher></mods:originInfo><mods:genre>Maqola</mods:genre></mods:mods>